Anticancer Activity of the Bioreductive and Non-Bioreductive Zerumbone Derivatives

被引：11

作者：

Pitchuanchom, Siripit ^{[1
,2
]}

Songsiang, Uraiwan ^{[1
,2
]}

Weerapreeyakul, Natthida ^{[3
]}

Yenjai, Chavi ^{[1
,2
]}

机构：

[1] Khon Kaen Univ, Dept Chem, Nat Prod Res Unit, Khon Kaen 40002, Thailand

[2] Khon Kaen Univ, Fac Sci, Ctr Innovat Chem, Khon Kaen 40002, Thailand

[3] Khon Kaen Univ, Fac Pharmaceut Sci, Ctr Res & Dev Herbal Hlth Prod, Khon Kaen 40002, Thailand

来源：

LETTERS IN DRUG DESIGN & DISCOVERY | 2011年 / 8卷 / 06期

关键词：

Bioreductive; KB; NCI-H187; MCF-7; Zerumbone derivatives; Zingiber zerumbet Smith; SESQUITERPENE; CELLS; ACTIVATION; APOPTOSIS; ESTERS;

D O I：

10.2174/157018011795906811

中图分类号：

R914 [药物化学];

学科分类号：

100701 ;

摘要：

Zerumbonoquinone 10 and zerumbonaminone 11 have been designed to release toxic moieties selectively and preferentially under reductive conditions. These compounds were synthesized by coupling the quinone delivery system with zerumbone alcohol 8 and amine 9. All compounds were evaluated for cytotoxicity against KB (non reductase over-expressing cells), NCI-H187 and MCF-7 (reductase overexpressing cells) and normal cells (Vero cells). Bioreductive compounds 10 and 11 were found to act as bioreductive anticancer agents exhibiting less cytotoxicity than the parents 8 and 9 in KB cells with good stability, and were partially bioreductively active against MCF-7 and NCI-H187 cells.

引用

页码：536 / 543

页数：8

共 50 条

[41] Bioreductive activation of a series of indolequinones by human DT-diaphorase: Structure-activity relationships
Phillips, RM
Naylor, MA
Jaffar, M
Doughty, SW
Everett, SA
Breen, AG
Choudry, GA
Stratford, IJ
JOURNAL OF MEDICINAL CHEMISTRY, 1999, 42 (20) : 4071 - 4080
[42] POTENTIAL BIOREDUCTIVE ALKYLATING-AGENTS .2. ANTITUMOR EFFECT AND BIOCHEMICAL STUDIES OF NAPHTHOQUINONE DERIVATIVES
LIN, AJ
PARDINI, RS
COSBY, LA
LILLIS, BJ
SHANSKY, CW
SARTORELLI, AC
JOURNAL OF MEDICINAL CHEMISTRY, 1973, 16 (11) : 1268 - 1271
[43] 2,3-DIMETHYL-1,4-NAPHTHOQUINONE DERIVATIVES AS POTENTIAL BIOREDUCTIVE ALKYLATING-AGENTS
LIN, TS
ANTONINI, I
COSBY, LA
SARTORELLI, AC
ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 1982, 183 (MAR): : 70 - MEDI
[44] Structure-activity study of the interaction of bioreductive benzoquinone alkylating agents with DNA topoisomerase II
Brian B. Hasinoff
Xing Wu
Asher Begleiter
Lynn J. Guziec
Frank Guziec
Angela Giorgianni
Shaohua Yang
Yu Jiang
Jack C. Yalowich
Cancer Chemotherapy and Pharmacology, 2006, 57 : 221 - 233
[45] The mitomycin bioreductive antitumor agents: Cross-linking and alkylation of DNA as the molecular basis of their activity
Tomasz, M
Palom, Y
PHARMACOLOGY & THERAPEUTICS, 1997, 76 (1-3) : 73 - 87
[46] DT-DIAPHORASE ACTIVITY IN NORMAL AND NEOPLASTIC HUMAN TISSUES - AN INDICATOR FOR SENSITIVITY TO BIOREDUCTIVE AGENTS
SMITSKAMPWILMS, E
GIACCONE, G
PINEDO, HM
VANDERLAAN, BFAM
PETERS, GJ
BRITISH JOURNAL OF CANCER, 1995, 72 (04) : 917 - 921
[47] Cytotoxic mechanisms of FK317, a new class of bioreductive agent with potent antitumor activity
Naoe, Y
Inami, M
Kawamura, I
Nishigaki, F
Tsujimoto, S
Matsumoto, S
Manda, T
Shimomura, K
JAPANESE JOURNAL OF CANCER RESEARCH, 1998, 89 (06): : 666 - 672
[48] Structure-activity study of the interaction of bioreductive benzoquinone alkylating agents with DNA topoisomerase II
Hasinoff, BB
Wu, X
Begleiter, A
Guziec, LJ
Guziec, F Jr
Giorgianni, A
Yang, SH
Jiang, Y
Yalowich, JC
CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2006, 57 (02) : 221 - 233
[49] Coenzyme Q10 as an Inhibitor of Effector Release from One-Electron-Reduced Bioreductive Anticancer Prodrugs
Anderson, Robert F.
Qi, Wen
MOLECULES, 2025, 30 (04):
[50] Nitrobenzocyclophosphamides as potential prodrugs for bioreductive activation: Synthesis, stability, enzymatic reduction, and antiproliferative activity in cell culture
Li, ZR
Han, JY
Jiang, YY
Browne, P
Knox, RJ
Hu, LQ
BIOORGANIC & MEDICINAL CHEMISTRY, 2003, 11 (19) : 4171 - 4178

← 1 2 3 4 5 →